BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.73 +0.35%

+$0.05 today

Market cap
$342.42M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.12M

Average 0.15M

Returns on capital

BrainsWay Ltd. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

10.4%

avg -28.1%

ROIC

4.7%

avg -16.2%

ROA

6.8%

avg -13.9%

Analysis

ROE is currently the strongest return metric at 10.4% versus its period average of -28.1%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Hadar Levy

Chief Executive OfficerUSD 687.98K5362.50K0.16%

Ido Marom

Chief Financial OfficerUSD 430.8K5017.50K0.04%

Michael Cohen

Vice President of US SalesUSD 377.3K———

Colleen Hanlon

Vice President of Medical AffairsUSD 331.49K4610.00K0.03%

Gilead Moiseyev

Chief Technology OfficerUSD 309.81K54——

Yiftach Roth

Founder & Chief Scientific OfficerUSD 108K551.08M2.75%

Abraham Zangen

Co-Founder, Member of Scientific Advisory Board & DirectorUSD 72.18K5625.00K0.06%

David Zacut

Co-Founder & Vice-ChairmanUSD 42.97K7325.00K0.06%

Dor Hagai

Vice President of Operations————

Menachem C. Klein

Vice President, General Counsel & Corporate Secretary————

Naomi Rozenfeld

Chief Marketing Officer—4125.00K0.06%

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 18, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

3

$0.00

Net Transaction Value

Neutral

Balanced transaction value

Most Active

Mitrany Rayten Michal Ety

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Jun 15, 26

Moiseyev Gilad

Direct

Sell$0
May 26, 26

Mitrany Rayten Michal Ety

Direct

Sell$0
May 25, 26

Mitrany Rayten Michal Ety

Direct

Sell$0

Summary

Insiders reported 0 buys worth $0.00 and 3 sells worth $0.00 over the last 12 months. Reported purchase and sale values were balanced. Mitrany Rayten Michal Ety was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
+13.8% (3yr)1 analysts
RevenueN/AN/A+24.3%
+24.9% (3yr)2 analysts
Net IncomeN/AN/AN/A
+13.6% (3yr)2 analysts
EBITN/AN/AN/A
+52.9% (3yr)2 analysts

Analysis

Recent growth has been strongest in Revenue at +24.3% over three years. Forward estimates point to EBIT at +52.9% (3yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does BrainsWay Ltd. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about BWAY's management, answered from reported figures.

Who manages BWAY?

BrainsWay Ltd. (BWAY) lists 11 active executives. The top listed executive is David Zacut, Co-Founder & Vice-Chairman.

Are BWAY insiders buying or selling?

Recent insider activity shows net buying of $0.00.